Research on Optimization of Management Process for Rational Use of Anti Tumor Drugs and Patient Burden Evaluation Based on Medical Insurance Payment Standards
With the national negotiation of anti-tumor targeted drugs into the medical insurance payment,the medical burden of patients with malignant tumor continues to reduce.This study is based on the medical insurance payment standards and the management practices of Tianjin Cancer Hospital Airport Hospital,to construct and optimize the hospital management process for the rational use of anti-tumor targeted drugs,providing reference for the optimization of medical insurance payment policies and the rational use of drugs.This study outlines the main policy contents of medical insurance product negotiations.The rational use of anti-tumor targeted drugs in hospital was taken as the research content,combined with the management practice of the rational use of anti-tumor targeted drugs,the supervision system of the rational use of anti-tumor targeted drugs was constructed.By comparing the changes of patients'personal burden before and after the inclusion of medical insurance payment.The research results propose to further promote the implementation of negotiation drugs and the expansion of payment standards from a policy perspective.From the perspective of medical institution management,it is necessary to continuously optimize management processes,strengthen supervision of the use of medical insurance funds,ensure patient medication needs,and promote the rational use of drugs and medical insurance funds.At the policy level,it is recommended to adjust the medical insurance payment standards in a timely manner based on changes in drug instructions,further improving the accessibility of medication for cancer patients.The research conclusion provides policy recommendations for the medical insurance management department to continue national negotiations on valuable drugs and effectively reduce the personal burden of malignant tumor patients.
medical insurance paymenttargeted drugsmanagement processpersonal burdencost evaluationrational administration of drug